Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa03015 | mRNA surveillance pathway | 30/1171 | 97/8135 | 0.0000227 | 0.001512 | 0.001161 | 30 | RABC68 | |
| KEGG | hsa00280 | Valine, leucine and isoleucine degradation | 18/1171 | 48/8135 | 0.0000618 | 0.003429 | 0.002634 | 18 | RABC68 | |
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 27/1171 | 89/8135 | 0.0000835 | 0.003972 | 0.003051 | 27 | RABC68 | |
| KEGG | hsa04932 | Non-alcoholic fatty liver disease | 40/1171 | 155/8135 | 0.0001165 | 0.004809 | 0.003694 | 40 | RABC68 | |
| KEGG | hsa05415 | Diabetic cardiomyopathy | 49/1171 | 203/8135 | 0.00013 | 0.004809 | 0.003694 | 49 | RABC68 | |
| KEGG | hsa05012 | Parkinson disease | 60/1171 | 266/8135 | 0.0001863 | 0.006184 | 0.00475 | 60 | RABC68 | |
| KEGG | hsa03013 | Nucleocytoplasmic transport | 30/1171 | 108/8135 | 0.0002043 | 0.006184 | 0.00475 | 30 | RABC68 | |
| KEGG | hsa05132 | Salmonella infection | 56/1171 | 249/8135 | 0.0003273 | 0.009083 | 0.006977 | 56 | RABC68 | |
| KEGG | hsa03010 | Ribosome | 39/1171 | 158/8135 | 0.0003803 | 0.009742 | 0.007483 | 39 | RABC68 | |
| KEGG | hsa04659 | Th17 cell differentiation | 29/1171 | 108/8135 | 0.0004825 | 0.01148 | 0.008816 | 29 | RABC68 | |
| KEGG | hsa03040 | Spliceosome | 36/1171 | 147/8135 | 0.000735 | 0.01632 | 0.01253 | 36 | RABC68 | |
| KEGG | hsa05169 | Epstein-Barr virus infection | 71/1069 | 202/8135 | 5.24e-16 | 0.000000000000172 | 0.000000000000111 | 71 | RABC9 | |
| KEGG | hsa05171 | Coronavirus disease - COVID-19 | 70/1069 | 232/8135 | 0.00000000000444 | 0.000000000731 | 0.00000000047 | 70 | RABC9 | |
| KEGG | hsa04380 | Osteoclast differentiation | 45/1069 | 128/8135 | 0.000000000132 | 0.0000000145 | 0.00000000934 | 45 | RABC9 | |
| KEGG | hsa05140 | Leishmaniasis | 32/1069 | 77/8135 | 0.000000000495 | 0.0000000408 | 0.0000000262 | 32 | RABC9 | |
| KEGG | hsa05330 | Allograft rejection | 20/1069 | 38/8135 | 0.0000000064 | 0.000000421 | 0.000000271 | 20 | RABC9 | |
| KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 60/1069 | 222/8135 | 0.0000000172 | 0.000000943 | 0.000000607 | 60 | RABC9 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 33/1069 | 92/8135 | 0.0000000223 | 0.00000105 | 0.000000673 | 33 | RABC9 | |
| KEGG | hsa05416 | Viral myocarditis | 25/1069 | 60/8135 | 0.0000000371 | 0.00000153 | 0.000000982 | 25 | RABC9 | |
| KEGG | hsa04940 | Type I diabetes mellitus | 20/1069 | 43/8135 | 0.0000000952 | 0.00000348 | 0.00000224 | 20 | RABC9 | |
| KEGG | hsa05323 | Rheumatoid arthritis | 32/1069 | 93/8135 | 0.000000112 | 0.00000369 | 0.00000238 | 32 | RABC9 | |
| KEGG | hsa04660 | T cell receptor signaling pathway | 34/1069 | 104/8135 | 0.000000187 | 0.00000559 | 0.0000036 | 34 | RABC9 | |
| KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 32/1069 | 97/8135 | 0.000000339 | 0.00000929 | 0.00000598 | 32 | RABC9 | |
| KEGG | hsa04064 | NF-kappa B signaling pathway | 33/1069 | 104/8135 | 0.000000616 | 0.0000156 | 0.00001 | 33 | RABC9 | |
| KEGG | hsa04662 | B cell receptor signaling pathway | 28/1069 | 82/8135 | 0.00000083 | 0.0000195 | 0.0000126 | 28 | RABC9 | |
| KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 38/1069 | 131/8135 | 0.00000113 | 0.0000247 | 0.0000159 | 38 | RABC9 | |
| KEGG | hsa04672 | Intestinal immune network for IgA production | 20/1069 | 49/8135 | 0.00000128 | 0.0000264 | 0.000017 | 20 | RABC9 | |
| KEGG | hsa04659 | Th17 cell differentiation | 33/1069 | 108/8135 | 0.0000016 | 0.0000307 | 0.0000197 | 33 | RABC9 | |
| KEGG | hsa05340 | Primary immunodeficiency | 17/1069 | 38/8135 | 0.00000174 | 0.0000307 | 0.0000197 | 17 | RABC9 | |
| KEGG | hsa04640 | Hematopoietic cell lineage | 31/1069 | 99/8135 | 0.00000185 | 0.0000307 | 0.0000197 | 31 | RABC9 |